Stockscreener 앱 받기
3.50
3.85%
-0.14
시간 외 거래:
3.54
0.04
+1.14%
전일 마감가:
$3.64
열려 있는:
$3.55
하루 거래량:
540.17K
Relative Volume:
0.14
시가총액:
$39.93M
수익:
$32.77M
순이익/손실:
$-101.98M
주가수익비율:
-0.3642
EPS:
-9.6101
순현금흐름:
$-112.43M
1주 성능:
-6.79%
1개월 성능:
+117.39%
6개월 성능:
-68.30%
1년 성능:
-82.72%
1일 변동 폭
$3.27
$3.64
1주일 범위
$3.0235
$3.79
52주 변동 폭
$1.35
$26.83
X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile
명칭
X 4 Pharmaceuticals Inc
전화
857-529-8300
주소
61 NORTH BEACON STREET, BOSTON, MA
XFOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XFOR
X 4 Pharmaceuticals Inc
|
3.50 | 81.71M | 32.77M | -101.98M | -112.43M | -9.6101 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
X 4 Pharmaceuticals Inc Stock (XFOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-12 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2023-08-30 | 재개 | B. Riley Securities | Buy |
| 2022-12-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-12-12 | 개시 | Piper Sandler | Overweight |
| 2019-12-23 | 개시 | Oppenheimer | Outperform |
| 2019-12-18 | 개시 | ROTH Capital | Buy |
| 2019-12-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-12-05 | 개시 | B. Riley FBR | Buy |
| 2019-06-07 | 개시 | Stifel | Buy |
| 2019-06-05 | 개시 | Cowen | Outperform |
모두보기
X 4 Pharmaceuticals Inc 주식(XFOR)의 최신 뉴스
Is X4 Pharmaceuticals Inc. a top pick in the sectorEarnings Miss & Accurate Intraday Trading Signals - خودرو بانک
Short Interest in X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Expands By 142.2% - Defense World
Will X4 Pharmaceuticals Inc. stock go up in YEARM&A Rumor & Entry Point Confirmation Alerts - خودرو بانک
What are analysts’ price targets for X4 Pharmaceuticals Inc.Breakout Watch & Daily Profit Maximizing Tips - خودرو بانک
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Identifying reversal signals in X4 Pharmaceuticals Inc.2025 Top Decliners & Smart Swing Trading Techniques - Newser
How to use a screener to detect X4 Pharmaceuticals Inc. breakoutsJuly 2025 Analyst Calls & Growth Focused Investment Plans - Newser
Is X4 Pharmaceuticals Inc. forming a reversal patternJobs Report & High Return Trade Guides - Newser
What’s the beta of X4 Pharmaceuticals Inc. stockJuly 2025 Chart Watch & Real-Time Stock Price Movement Reports - خودرو بانک
X4 Pharmaceuticals Inc. stock prediction for this weekBond Market & Weekly Return Optimization Alerts - Newser
Will X4 Pharmaceuticals Inc. stock go up soonEarnings Recap Summary & Consistent Return Investment Signals - Newser
Charles Schwab Investment Management Inc. Boosts Stake in X4 Pharmaceuticals, Inc. $XFOR - Defense World
Is X4 Pharmaceuticals Inc. stock a value trapJuly 2025 Macro Moves & Breakout Confirmation Alerts - خودرو بانک
Price momentum metrics for X4 Pharmaceuticals Inc. explainedMarket Performance Recap & Safe Entry Momentum Tips - Newser
Is X4 Pharmaceuticals Inc. forming a breakout patternJuly 2025 Macro Moves & AI Powered Market Entry Strategies - خودرو بانک
X4 Pharmaceuticals Inc. stock trendline breakdownMarket Volume Summary & AI Enhanced Trading Signals - Newser
Using R and stats models for X4 Pharmaceuticals Inc. forecasting2025 Earnings Surprises & AI Driven Price Predictions - Newser
Applying chart zones and confluence areas to X4 Pharmaceuticals Inc.July 2025 Review & Entry Point Confirmation Signals - Newser
What to expect from X4 Pharmaceuticals Inc. in the next 30 daysOptions Play & Real-Time Market Sentiment Alerts - Newser
X4 Pharmaceuticals Inc. stock outlook for YEARPortfolio Return Summary & Verified Momentum Stock Watchlist - Newser
How to recover losses in X4 Pharmaceuticals Inc. stockInsider Buying & Step-by-Step Swing Trade Plans - Newser
Is X4 Pharmaceuticals Inc. trending in predictive chart modelsShort Setup & Advanced Technical Analysis Signals - Newser
Is X4 Pharmaceuticals Inc. stock ready for a breakout2025 Market Outlook & Fast Exit and Entry Strategy Plans - Newser
X4 Pharmaceuticals Inc. stock trend forecastQuarterly Portfolio Review & Safe Swing Trade Setups - Newser
Intraday pattern recognizer results for X4 Pharmaceuticals Inc.2025 Volume Leaders & Free High Return Stock Watch Alerts - Newser
Is X4 Pharmaceuticals Inc. stock entering bullish territoryDividend Hike & Smart Allocation Stock Reports - Newser
What is the target price for X4 Pharmaceuticals Inc. stockRate Cut & AI Enhanced Market Trend Forecasts - خودرو بانک
Trend analysis for X4 Pharmaceuticals Inc. this weekQuarterly Portfolio Report & AI Forecast for Swing Trade Picks - Newser
X4 Pharmaceuticals Inc. stock daily chart insightsInsider Buying & Daily Stock Trend Watchlist - Newser
Is X4 Pharmaceuticals Inc. stock influenced by commodity prices2025 Market Overview & AI Driven Price Predictions - خودرو بانک
Multi asset correlation models including X4 Pharmaceuticals Inc.Long Setup & Real-Time Chart Breakout Alerts - Newser
Real time breakdown of X4 Pharmaceuticals Inc. stock performanceMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser
What Fibonacci levels say about X4 Pharmaceuticals Inc. reboundJuly 2025 Update & Trade Opportunity Analysis - Newser
X 4 Pharmaceuticals Inc (XFOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
X 4 Pharmaceuticals Inc 주식 (XFOR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Baldry Mark | Chief Commercial Officer |
Nov 15 '24 |
Buy |
0.34 |
13,404 |
4,598 |
129,173 |
| Ragan Paula | President and CEO |
Jan 24 '25 |
Sale |
0.45 |
76,473 |
34,719 |
1,087,386 |
| Mostafa Adam S. | Chief Financial Officer |
Jan 24 '25 |
Sale |
0.45 |
74,773 |
33,947 |
0 |
| Baldry Mark | Chief Commercial Officer |
Jan 24 '25 |
Sale |
0.45 |
29,159 |
13,241 |
94,123 |
| DiBiase Mary | Chief Operating Officer |
Jan 24 '25 |
Sale |
0.45 |
22,258 |
10,094 |
490,980 |
| Arbet-Engels Christophe | Chief Medical Officer |
Jan 24 '25 |
Sale |
0.45 |
11,624 |
5,284 |
14,207 |
1.40%
자본화:
|
볼륨(24시간):